Results 21 to 30 of about 1,120 (174)
Linfoma No Hodgkin Primario de Mama: Reporte de un Caso.
ARS Medica, 2016 El linfoma no Hodgkin primario de la mama es una patología poco frecuente, constituye menos del 0,5% de todos los tumores mamarios malignos, debido a que carecen de características propias, tanto clínicas, mamográficas como ultrasonográficas.
H. Gámez Oliva +5 more
doaj +1 more source
Assessing patient perspectives on enrollment in lymphoma clinical trials
Cancer, Volume 132, Issue 8, 15 April 2026.Abstract Background Clinical trials drive advances in lymphoma care, yet certain patient groups including socioeconomically disadvantaged, racial/ethnic groups, and women remain underrepresented. Given limited/inconsistent data regarding solutions to improve clinical trial enrollment of these groups, the authors performed a study to assess patient ...
Neha Akkad +14 more
wiley +1 more source
Linfoma no hodgkiniano abdominal. Presentación de un caso
Medimay, 2014 El linfoma no hodgkiniano de los niños es una neoplasia maligna originada en el sistema linfoverticular de curso generalmente fatal hasta hace poco años. Es la segunda causa de muerte por cáncer en los niños de nuestro país y es frecuente que se presente
Luz Vivian Dorvigny Linares +2 more
doaj +4 more sources
Hematology, Transfusion and Cell Therapy, 2021 Introdução: Leucemia de células plasmocitárias (LCP) é uma neoplasia muito agressiva e rara. Mais inédito ainda é a ocorrência de LCP no paciente com diagnóstico prévio de linfoma de Hodgkin e leucemia linfocítica crônica (LLC).
LFS Dias +9 more
doaj +1 more source
Medisur, 2023 Acquired immunodeficiency virus infection continues to be a major public health problem not only in Ecuador but also throughout the world. Cancer is a common presentation in people living with this virus and represents the main cause of death in this ...
Edwin Marcelo Miranda Solìs +1 more
doaj
Quality of Life and Needs of Patients Undergoing CAR‐T Cell Therapy: The Patients’ Perspective
European Journal of Cancer Care, Volume 2026, Issue 1, 2026.Background Despite the strong emphasis in recent scientific literature on the pharmacological features of CAR‐T cells, patients’ quality of life (QoL) and needs, by contrast, have received little attention. Aim This study aims to investigate patients’ perspectives on their QoL and needs in a referral centre for CAR‐T cell treatment in Italy.
S. Alfieri +10 more
wiley +1 more source
Cancer, Volume 131, Issue 24, 15 December 2025.Abstract Background Clinical trials (CTs) are essential for expanding treatment options across hematologic malignancies (HM) and providing access to novel treatments. However, older adults with HM are often underrepresented in CTs, and a national‐level evaluation of factors influencing their participation is lacking.
Inna Y. Gong +8 more
wiley +1 more source
Acta Médica Peruana, 2011 bjetivo: Conocer las características epidemiológicas, clínicas y patológicas de los pacientes con linfoma diagnosticados en el Hospital Nacional Cayetano Heredia. Material y métodos: Se realizó un estudio descriptivo, retrospectivo, tipo serie de casos
Juan José Padilla Valdez +2 more
doaj
Hematology, Transfusion and Cell TherapyObjetivo: Correlacionamos os diagnósticos de linfoma de Hodgkin e linfoma não - Hodgkin em pacientes atendidos no hospital de referência oncológica da Paraíba, durante período 2019/2023, analisando as variáveis pré e pós-pandemia de COVID-19 e influência
MAOM Teixeira +8 more
doaj +1 more source
Linfoma no Hodgkin primario de vagina [PDF]
Revista chilena de obstetricia y ginecología, 2013 La afectacion primaria del tracto genital femenino de los linfomas no Hodgkin es poco frecuente (2% de los linfomas primarios extraganglionares). Los organos mas afectados son los ovarios seguidos del cervix, siendo la localizacion endometrial y vaginal extremadamente rara.
Iglesias Rodríguez, María Begoña +5 more
openaire +2 more sources